Skip to main content
Clinical Trials/NCT03785795
NCT03785795
Completed
Not Applicable

Optimizing and Validating an EMG-based Fetal Monitor to Identify True Preterm Labor

PreTeL, Inc1 site in 1 country23 target enrollmentNovember 25, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy Preterm
Sponsor
PreTeL, Inc
Enrollment
23
Locations
1
Primary Endpoint
Validating prediction of true/false labor status with delivery within 24 hours
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

We have designed new electromyography sensors for measuring uterine activity. These sensors are directional - they preferentially report uterine muscle contractions at specific locations, called regions. By measuring the synchronization of the regions of the uterus during contractions we intend to non-invasively determine if any patient is in-labor or not-in-labor. Accurately diagnosing true preterm labor allows timely intervention to avoid preterm birth; Accurately diagnosing false preterm labor avoids needlessly treating patients who would not benefit.

Detailed Description

The legacy device for assessing uterine contractions is the tocodynamometer (Toco). The Toco is plunger-driven device that measures the uterine shape change that occurs with a contraction. Toco only reports the timing of contractions, not the contraction strength, and cannot distinguish between false and true labor. Our overarching goal is to validate our method of determining if a patient experiencing contractions is in true labor or false labor. We will accomplish this by applying new knowledge to an old technology - uterine EMG. This trial is based on our advanced understanding of how the uterus generates coordinated contractions without a pacemaker or dedicated electrical conduction pathways - mechanotransduction and intrauterine pressure - but also uses bioelectrical signaling for local tissue recruitment. The uterus emits bioelectrical signals with each contraction that can be detected by electromyography (EMG). To observe uterine bioelectrical signals, we created a novel EMG sensor, we call the "area sensor". This sensor is directional - capable of preferentially reporting muscle contractions from immediately below the sensor location. In this clinical trial we use multiple area sensors placed on the maternal abdomen to directly observe how well the regional contractions are synchronized. Our hypothesis to be tested is that highly synchronized contractions predicts true labor, unsynchronized predicts false labor. Patients with unclear labor status, or those in early labor will be studied. We will correlate the results of the synchronization analysis against the patient's progress over the ensuing 24 hours. These data will validate the ability to identify false and true labor using multichannel EMG and area sensors.

Registry
clinicaltrials.gov
Start Date
November 25, 2018
End Date
January 10, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • One living fetus
  • Experiencing frequent uterine contractions

Exclusion Criteria

  • Cervical dilation \> 4 cm
  • Ruptured membranes
  • Maternal or fetal indications for immediate delivery

Outcomes

Primary Outcomes

Validating prediction of true/false labor status with delivery within 24 hours

Time Frame: 24 hours

The test device predicts delivery. The prediction on each subject will be compared against the observed delivery time.

Secondary Outcomes

  • Establishing the range and trend of synchronized sensor readings(48 hours)

Study Sites (1)

Loading locations...

Similar Trials